Hemoptysis and acute respiratory syndrome (ARDS) as delayed-type hypersensitivity after FOLFOX4 plus bevacizumab treatment.

about

Hypersensitivity reactions associated with oxaliplatin and their clinical management.Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study

P2860

Q38259295-46315663-68F3-45FC-9E5A-10984CE4D852 Q41439263-3BB672B2-4564-4579-BDB0-2C076C7570E7

P2860

Hemoptysis and acute respiratory syndrome (ARDS) as delayed-type hypersensitivity after FOLFOX4 plus bevacizumab treatment.

Item

http://www.wikidata.org/entity/Q41810095

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Hemoptysis and acute respirato ...... X4 plus bevacizumab treatment.

@en

type

Item

label

Hemoptysis and acute respirato ...... X4 plus bevacizumab treatment.

@en

prefLabel

Hemoptysis and acute respirato ...... X4 plus bevacizumab treatment.

@en

P1476

Hemoptysis and acute respirato ...... X4 plus bevacizumab treatment.

@en

P2093

Hiroyoshi Matsuoka

http://www.w3.org/2001/XMLSchema#string

Koji Kogawa

http://www.w3.org/2001/XMLSchema#string

Masanori Sugiyama

http://www.w3.org/2001/XMLSchema#string

Tadahiko Masaki

http://www.w3.org/2001/XMLSchema#string

Takaaki Kobayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS.

Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database.

Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial.

Serum IL-6, TNFalpha and CRP levels in Greek colorectal cancer patients: prognostic implications.

Systemic therapy for metastatic colorectal cancer: current options, current evidence.

Hypersensitivity reactions to oxaliplatin and other antineoplastic agents.

Diagnosis and management of hypersensitivity reactions related to common cancer chemotherapy agents.

A review on the use of molecular markers of cytotoxic therapy for colorectal cancer, what have we learned?

Serum interleukin-6 levels in colorectal cancer patients--a summary of published results.

P304

445-449

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.9738/INTSURG-D-12-00020.1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24229039

http://www.w3.org/2001/XMLSchema#string

P921

acute respiratory distress syndrome

bevacizumab

hemoptysis

P932

3829079

http://www.w3.org/2001/XMLSchema#string

Hemoptysis and acute respiratory syndrome (ARDS) as delayed-type hypersensitivity after FOLFOX4 plus bevacizumab treatment.

about

P2860

P2860

Hemoptysis and acute respiratory syndrome (ARDS) as delayed-type hypersensitivity after FOLFOX4 plus bevacizumab treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932